These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 12180053)
21. Escherichia coli: development of carbapenem resistance during therapy. Hong T; Moland ES; Abdalhamid B; Hanson ND; Wang J; Sloan C; Fabian D; Farajallah A; Levine J; Thomson KS Clin Infect Dis; 2005 May; 40(10):e84-6. PubMed ID: 15844056 [TBL] [Abstract][Full Text] [Related]
22. [Clinical studies of efficacy of imipenem/cilastatin sodium against urinary tract infections with ureterocutaneostomy]. Yogi S; Yoshikawa H; Ikeuchi T; Kai Y Hinyokika Kiyo; 1992 Mar; 38(3):373-7. PubMed ID: 1523997 [TBL] [Abstract][Full Text] [Related]
23. Changing role of carbapenems in the treatment of lower respiratory tract infections. Lode H; Hamacher J; Eller J; Schaberg T Scand J Infect Dis Suppl; 1995; 96():17-23. PubMed ID: 7652498 [TBL] [Abstract][Full Text] [Related]
24. [Clinical significance of microbiological monitoring of infective agents in an urological hospital in the selection of antibacterial therapy regimens]. Derevianko II; Nefedova LA; Lavrinova LN; Prudnikova SA Urologiia; 2001; (4):11-5. PubMed ID: 11569227 [TBL] [Abstract][Full Text] [Related]
25. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system]. Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514 [TBL] [Abstract][Full Text] [Related]
26. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections. Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941 [TBL] [Abstract][Full Text] [Related]
27. [Efficacy of sodium imipenem/cilastatin on patients of complicated urinary tract infections--following the failure of prior antimicrobial agents]. Yoshida K; Kobayashi N; Tohsaka A; Uchijima Y; Takeuchi S; Saitoh H; Negishi T; Yamada T; Nagamatsu H; Masuda H Hinyokika Kiyo; 1992 Apr; 38(4):495-9. PubMed ID: 1529826 [TBL] [Abstract][Full Text] [Related]
28. [Efficacy and tolerance of imipenem/cilastatin in the adjuvant treatment of surgery for peritonitis in patients over the age of 70 years]. Janvier G; Carles J Ann Chir; 1993; 47(4):370-5. PubMed ID: 8352517 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of IPM/CS in gram-negative bacillus infections: use of an endotoxin-specific assay. Endo S; Inada K; Inoue Y; Yamada Y; Fujii N; Nagasawa T; Kikuchi M; Taki K; Hoshi S; Yoshida M Clin Ther; 1990; 12(4):352-6. PubMed ID: 2224949 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the efficacy and safety of imipenem/cilastatin in the treatment of complicated urinary tract infections. Goldoni S; Gandolfi P; Tubaro A; Vicentini C; Lancione P; Miano L J Chemother; 1989 Jul; 1(4 Suppl):845-7. PubMed ID: 16312665 [No Abstract] [Full Text] [Related]
32. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Babinchak T; Ellis-Grosse E; Dartois N; Rose GM; Loh E; ; Clin Infect Dis; 2005 Sep; 41 Suppl 5():S354-67. PubMed ID: 16080073 [TBL] [Abstract][Full Text] [Related]
33. Treatment of complicated intra-abdominal infections: comparison of the tolerability and safety of intravenous/oral trovafloxacin versus intravenous imipenem/cilastatin switching to oral amoxycillin/clavulanic acid. Luke DR; Peterson J Int J Clin Pract; 1999; 53(3):166-73. PubMed ID: 10665126 [TBL] [Abstract][Full Text] [Related]
35. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy. Wells WG; Woods GL; Jiang Q; Gesser RM J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185 [TBL] [Abstract][Full Text] [Related]
36. Imipenem-cilastatin in the treatment of hospital infections. Mao P; Enrichens F; Olivero G; Sciascia C; Benedetto G; Franchello A; Olivero S J Chemother; 1991 Jan; 3 Suppl 1():205-7. PubMed ID: 12041766 [TBL] [Abstract][Full Text] [Related]
37. [Bacterial and clinical studies on imipenem/cilastatin sodium in urological infection]. Goto T; Kawahara M; Sakamoto N; Ohi Y; Nagata S; Yanase I; Hanabusa A; Imamura A; Shimada T; Kawabata T Jpn J Antibiot; 1986 Apr; 39(4):996-1006. PubMed ID: 3463772 [TBL] [Abstract][Full Text] [Related]
38. [Efficacy of imipenem-cilastatin in combined therapy of severe anaerobic-aerobic infection of bones and soft tissues]. Goriunov SV; Romashov DV; Butivshchenko IA; Il'ianina AA; Mikhal'skiĭ VV; Rog AA; Polikarpova SV Khirurgiia (Mosk); 2002; (7):50-6. PubMed ID: 12162087 [No Abstract] [Full Text] [Related]
39. [Treatment in the event of antibiotic prophylaxis failure in gynecologic surgery. A retrospective study of 20 cases]. Paparella P; Zullo MA; Astorri AL; Bondì M; Maglione A; Oliva C; Mancuso Bondì S Minerva Ginecol; 1994 Sep; 46(9):499-503. PubMed ID: 7984331 [TBL] [Abstract][Full Text] [Related]
40. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center. Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]